Stone Summit Wealth’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Stone Summit Wealth's MRK Position: Q2 2026 in Review
Stone Summit Wealth reduced its Merck (MRK) stake by 0.8% in Q2 2026, selling an estimated $16.4K and leaving 17,426 shares worth $2.24M. The position accounts for 0.57% of the portfolio, ranked #52.
Stone Summit Wealth first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.88M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Stone Summit Wealth held 17,426 shares of Merck worth $2.24M as of Q2 2026.
- Stone Summit Wealth sold 140 Merck shares in Q2 2026, an estimated $16.4K.
- Merck made up 0.57% of Stone Summit Wealth's portfolio in Q2 2026, its #52 holding.
- Stone Summit Wealth first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
- Stone Summit Wealth's Merck position peaked at $3.88M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Stone Summit Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.